SE9103348L - Foerfarande foer framstaellning av en farmaceutisk komposition - Google Patents

Foerfarande foer framstaellning av en farmaceutisk komposition

Info

Publication number
SE9103348L
SE9103348L SE9103348A SE9103348A SE9103348L SE 9103348 L SE9103348 L SE 9103348L SE 9103348 A SE9103348 A SE 9103348A SE 9103348 A SE9103348 A SE 9103348A SE 9103348 L SE9103348 L SE 9103348L
Authority
SE
Sweden
Prior art keywords
poly
butylene succinate
pharmaceutical composition
preparing
procedure
Prior art date
Application number
SE9103348A
Other languages
Unknown language ( )
English (en)
Other versions
SE9103348D0 (sv
SE506448C2 (sv
Inventor
P Orsolini
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Publication of SE9103348D0 publication Critical patent/SE9103348D0/sv
Publication of SE9103348L publication Critical patent/SE9103348L/sv
Publication of SE506448C2 publication Critical patent/SE506448C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE9103348A 1990-11-14 1991-11-13 Förfarande för framställning av en farmaceutisk komposition innehållande en peptid SE506448C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3616/90A CH681425A5 (sv) 1990-11-14 1990-11-14

Publications (3)

Publication Number Publication Date
SE9103348D0 SE9103348D0 (sv) 1991-11-13
SE9103348L true SE9103348L (sv) 1992-05-15
SE506448C2 SE506448C2 (sv) 1997-12-15

Family

ID=4259807

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9103348A SE506448C2 (sv) 1990-11-14 1991-11-13 Förfarande för framställning av en farmaceutisk komposition innehållande en peptid

Country Status (12)

Country Link
JP (1) JPH04288021A (sv)
AT (1) AT397198B (sv)
BE (1) BE1004923A5 (sv)
CA (1) CA2055115A1 (sv)
CH (1) CH681425A5 (sv)
DE (1) DE4136930A1 (sv)
ES (1) ES2049617B1 (sv)
FR (1) FR2668707B1 (sv)
GB (1) GB2249725B (sv)
IT (1) IT1252870B (sv)
NL (1) NL9101877A (sv)
SE (1) SE506448C2 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
WO2004096178A1 (en) * 2003-05-02 2004-11-11 The University Of Nottingham Nano and microparticle drug delivery systems comprising polyesters containing aliphatic dicarboxylate residues and residues of aliphatic polyols

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
US4481353A (en) * 1983-10-07 1984-11-06 The Children's Medical Center Corporation Bioresorbable polyesters and polyester composites
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
CH672887A5 (sv) * 1987-10-14 1990-01-15 Debiopharm Sa
CH679207A5 (sv) * 1989-07-28 1992-01-15 Debiopharm Sa
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.

Also Published As

Publication number Publication date
ATA223591A (de) 1993-07-15
GB2249725B (en) 1994-08-10
ES2049617B1 (es) 1997-03-16
JPH04288021A (ja) 1992-10-13
NL9101877A (nl) 1992-06-01
FR2668707B1 (fr) 1995-05-24
IT1252870B (it) 1995-06-28
ITBS910119A1 (it) 1993-05-08
FR2668707A1 (fr) 1992-05-07
BE1004923A5 (fr) 1993-02-23
GB9123241D0 (en) 1991-12-18
SE9103348D0 (sv) 1991-11-13
SE506448C2 (sv) 1997-12-15
ITBS910119A0 (it) 1991-11-08
CA2055115A1 (en) 1992-05-15
AT397198B (de) 1994-02-25
CH681425A5 (sv) 1993-03-31
ES2049617A1 (es) 1994-04-16
DE4136930A1 (de) 1992-08-20
GB2249725A (en) 1992-05-20

Similar Documents

Publication Publication Date Title
BE1003093A3 (fr) Procede de preparation d'une composition pharmaceutique sous forme de microparticules.
DE3779933D1 (de) Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.
US20080063727A1 (en) Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
KR890001526A (ko) 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법
KR920002164A (ko) 연속 방출성 약학 조성물
EP0235986A1 (en) Slow release formulation
GB2237510B (en) Small particle drug compositions for nasal administration
KR920003962A (ko) 서방형 제제 및 그의 제조 방법
NO934573D0 (no) Farmasoeytiske formuleringer av osteorgeniske proteiner
AU6819294A (en) Oral drug delivery compositions and methods
IL102591A (en) Compositions for the sustained and controlled release of peptide medicaments and their preparation
KR850007559A (ko) 조절 펩타이드의 삽입식 제형
US7276251B2 (en) Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
KR970058724A (ko) 지속성 동물 성장 호르몬 제형 및 이의 제조 방법
JPS6442433A (en) Fine particle containing biodegradable polymer for controlling release of antimalarial effective component, medicinal composition and manufacture
SE9103348L (sv) Foerfarande foer framstaellning av en farmaceutisk komposition
KR910011241A (ko) 정제로 직접 압착 가능한 약제학적 분말 조성물을 제조하기 위한 분무 건조법
NZ514322A (en) Particle based vaccine composition
JP3240593B2 (ja) 可溶性コラーゲンパウダーを担体とする医薬徐放剤
KR20000051004A (ko) 히아루론산을 이용한 단백질 약물의 서방성 미세 입자 제형
KR880012206A (ko) 구강질환 치료 조성물

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9103348-0

Format of ref document f/p: F